First large scale vaccine trial began: VaxGen initiates Phase III trial of AIDSVAX (VAX004) in North America and The Netherlands involving over 5,400 volunteers.
First large scale vaccine trial in a developing country began: VaxGen initiates Phase III trial of AIDSVAX (VAX003) involving over 2,500 volunteers in Thailand.
Dedication of the Dale and Betty Bumpers Vaccine Research Center (VRC).
First African vaccine trial completed in Uganda.
Formation of Global HIV Vaccine Enterprise proposed in Science
Results of Phase III Thai Trial (RV144) show vaccine combination is first to demonstrate modest preventive effect in humans. The trial enrolled more than 16,000 volunteers.
Establishment of Pox-Protein Public-Private Partnership (P5)
Last Reviewed September 24, 2015